Full text is available at the source.
Abstract
Nanomaterial-based brain-targeted delivery systems may enhance therapeutic efficacy for glioblastoma treatment.
- Glioblastoma is associated with high morbidity and mortality due to challenges like the blood-brain barrier and blood-brain tumor barrier.
- Conventional drugs often face limitations such as poor penetration of the brain barrier, short half-lives, and low bioavailability.
- Innovative nanoparticle-mediated strategies are explored for improving drug transport kinetics in glioblastoma treatment.
- Biomimetic nanoparticles offer unique advantages that could facilitate more effective delivery of therapeutic agents.
- Current challenges and future research directions in this field may lead to better maximization of therapeutic effects for gene drugs or chemotherapeutic agents.
Simplified